(Q44418801)

2 December 2017

title

Analysis of metabolic parameters as predictors of risk in the RENAAL study (English)

1 reference

2 December 2017

Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL Study (English)

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

28 December 2023

4

Ralph A DeFronzo

1 reference

2 December 2017

Jai Radhakrishnan

2

1 reference

2 December 2017

Fernando Escobar-Jimenez

5

1 reference

2 December 2017

Ellen Burgess

7

1 reference

2 December 2017

Shahnaz Shahinfar

10

1 reference

2 December 2017

RENAAL Study

12

1 reference

2 December 2017

Gerald B. Appel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12716796

28 December 2023

Morrell M. Avram

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12716796

28 December 2023

M. M. Campos

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12716796

28 December 2023

Darcy A. Hille

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12716796

28 December 2023

Tania Z. Dickson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12716796

28 December 2023

Barry M. Brenner

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12716796

28 December 2023

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

2 December 2017

published in

Diabetes Care

1 reference

2 December 2017

volume

26

1 reference

2 December 2017

issue

5

1 reference

2 December 2017

page(s)

1402-1407

1 reference

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

2 December 2017

cites work

3

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

28 December 2023

4

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

28 December 2023

5

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study

28 December 2023

6

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)

28 December 2023

7

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications

28 December 2023

8

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme.

28 December 2023

10

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

Association between antihypertensive drug use and hypoglycemia: a case-control study of diabetic users of insulin or sulfonylureas

28 December 2023

11

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside, Scotland. Medicines Monitoring Unit

28 December 2023

12

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

Lipid abnormalities in renal disease

28 December 2023

13

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

Focal and segmental glomerulosclerosis: analogies to atherosclerosis

28 December 2023

15

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

Lipid abnormalities in renal disease

28 December 2023

16

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure

28 December 2023

17

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats

28 December 2023

18

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

Obesity associated with hypertension or hyperlipidemia accelerates renal damage

28 December 2023

19

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

Hypercholesterolemia and the progression of the renal dysfunction in chronic renal failure patients

28 December 2023

21

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency

28 December 2023

22

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

Effects of hypertension and dyslipidemia on the decline in renal function

28 December 2023

23

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study.

28 December 2023

24

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

28 December 2023

25

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy

28 December 2023

26

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

28 December 2023

27

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

28 December 2023

28

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure

28 December 2023

30

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group

28 December 2023

31

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1402

28 December 2023

Identifiers

1 reference

2 December 2017

1 reference